What follow‑up schedule and tests (e.g., imaging, blood work) should I have to monitor for recurrence of Melanoma

MelanomaApril 9, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Follow-Up Monitoring for Melanoma Recurrence

Great question—regular follow-up is one of the most important parts of melanoma care. Let me walk you through what monitoring typically looks like.

The Core Follow-Up Strategy

According to the NCCN Guidelines for Patients: Melanoma (2025), your follow-up plan depends on how likely your melanoma is to return based on your stage and other risk factors. Here's what you should expect:

Physical Exams & Skin Checks

Your care team will examine you regularly to look for:

  • New or changing moles on your skin
  • Enlarged lymph nodes (the small bean-shaped structures in your neck, underarms, and groin that are part of your immune system)
  • Any signs of recurrence

Frequency: Your provider may expect to examine your skin and lymph nodes at least once a year, though higher-risk patients may need more frequent visits (every 3-6 months).


Self-Exams: The ABCDE Rule

Between doctor visits, you play an active role. The NCCN Guidelines recommend following the ABCDE rule to spot concerning changes early:

  • A (Asymmetry) — One half of a mole doesn't match the other half
  • B (Border) — Edges are irregular and hard to define
  • C (Color) — The spot has multiple colors (brown, black, pink, red, white, or blue)
  • D (Diameter) — Larger than 6mm (about the size of a pencil eraser)
  • E (Evolving) — The spot changes size, shape, or color over time

What to do: Check your skin regularly in front of a mirror (a handheld mirror helps), ideally with a partner. If you notice anything unusual, contact your doctor promptly.


Imaging & Blood Tests

Whether you need imaging (CT scans, PET scans) or blood work depends on your stage and risk factors:

  • Early-stage melanoma (Stage 1-2): Imaging is typically not routine unless you have symptoms or your doctor suspects recurrence
  • Advanced melanoma (Stage 3-4): More frequent imaging may be recommended to catch recurrence early

Your care team will explain how often you need imaging based on your specific situation.


Key Points to Remember

According to NCCN Guidelines:

  • Regular skin exams are essential — your provider should examine you at least annually
  • Self-exams matter — learn the ABCDE rule and check your skin regularly
  • Lymph node checks are important — your doctor will feel for enlarged nodes during visits
  • Your provider should explain your specific follow-up plan — ask about how often you need visits based on YOUR stage

Questions to Ask Your Oncologist

To personalize your follow-up plan, ask:

  1. "Based on my stage and risk factors, how often should I have follow-up appointments?"
  2. "Do I need imaging (CT or PET scans) as part of my follow-up, and if so, how often?"
  3. "Should I have any blood tests to monitor for recurrence?"
  4. "How should I do self-exams, and what changes should I report immediately?"
  5. "If I find an unusual spot, what should I do and who should I contact?"

Sun Protection & Prevention

While monitoring for recurrence, the NCCN Guidelines also emphasize preventing new melanomas:

  • Limit sun exposure (especially 10 AM–4 PM)
  • Wear protective clothing, wide-brim hats, and UV-protective sunglasses
  • Use broad-spectrum sunscreen (SPF 30+) and reapply every 2 hours
  • Avoid indoor tanning beds

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your specific follow-up schedule.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: